Aesthetic Preferences and Policy Preferences as Determinants of US Supreme Court Writing Style
Journal of Law and Courts · 2023-04 · 11 (1) · 45-66
DOI: 10.1086/717423 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Law and Courts, online erschienen am 03.04.2023. Verfasst von Jeffrey Budziak und 1 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Recent literature on writing style in US Supreme Court opinions has focused on style as a means of furthering justices’ policy goals. In particular, an opinion’s clarity is proposed to make the implementation of the announced policy more likely. We give a formal argument that the observed distribution of opinion clarity is not easily reconcilable with justices who are striving to write clearly in service of policy implementation-related goals; this is true even if there are case-level costs that sometimes make writing clearly more difficult. We propose that justices having aesthetic preferences – essentially, stylistic preferences over opinion language that are unrelated to policy implementation – that they weight heavily could explain the observed distribution of opinion clarity. Our analysis of some 4,500 majority opinions 1955–2008 is largely consistent with our theoretical argument.
Zitieren
APA
Budziak, J., & Lempert, D. (2023). Aesthetic Preferences and Policy Preferences as Determinants of US Supreme Court Writing Style. Journal of Law and Courts, 11(1), 45-66. https://doi.org/10.1086/717423
Vancouver
Budziak J, Lempert D. Aesthetic Preferences and Policy Preferences as Determinants of US Supreme Court Writing Style. Journal of Law and Courts. 2023;11(1):45-66. doi:10.1086/717423
BibTeX
@article{Budziak2023,
author = {Budziak, Jeffrey and Lempert, Daniel},
title = {Aesthetic Preferences and Policy Preferences as Determinants of US Supreme Court Writing Style},
journal = {Journal of Law and Courts},
year = {2023},
volume = {11},
number = {1},
pages = {45--66},
doi = {10.1086/717423}
}
EUVIMED